Fungal infection in the intensive care unit.
Fungal infection in critically ill patients is an increasingly prevalent problem. Candida spp. cause the majority of these infections in ICU. They occur most commonly in patients with severe underlying illness, multiple courses of antibiotics and intravascular catheters. Clinical diagnosis is difficult due to nonspecific signs and the frequent occurrence of widespread superficial colonization with Candida spp. in ventilated patients. Most patients are diagnosed using inferential evidence of infection, such as persistent pyrexia despite antibiotics, raised serum C-reactive protein and the presence of individual risk factors. Amphotericin B and fluconazole are the most commonly used anti-fungals dependent on the identity of the fungus. Most of these infections are endogenous; however, a proportion may be caused via the hands of healthcare staff or contaminated medical equipment.
Flanagan
P G
PG
Department of Medical Microbiology, University of Wales College of Medicine, Cardiff, UK.
Barnes
R A
RA
D000935:Antifungal Agents; D016638:Critical Illness; D003428:Cross Infection / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D004866:Equipment Contamination; D006801:Humans; D017053:Infection Control; D017757:Infectious Disease Transmission, Professional-to-Patient; D007362:Intensive Care Units; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D012307:Risk Factors
D000935:Antifungal Agents